UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C.  20549

                                  FORM 10-QSB

                                   (Mark  One)
  [X]  QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT
                                     OF 1934

                  For the quarterly period ended March 31, 2000
                               ------------------

  [ ]  TRANSITION  REPORT  UNDER  SECTION  13  OR  15(d)  OF  THE  EXCHANGE ACT

              For the period from ______________ to ______________

                        Commission file number    0-26445
                                                  -------


                        ACCESS HEALTH ALTERNATIVES, INC.
                        --------------------------------
        (Exact name of small business issuer as specified in its charter)


                 Florida                             59-3542362
                 -------                             ----------
               (State of other jurisdiction          (IRS Employer
        of incorporation or organization)            Identification No.)


                 4619 Parkbreeze Court, Orlando, Florida  32808
--------------------------------------------------------------------------------
                    (Address of principal executive offices)


                                 (407)  299-0629
                                 ---------------
                           (Issuer's Telephone Number)


--------------------------------------------------------------------------------
   (Former name, former address and former fiscal year, if changed since last
                                     report)



                APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY
                   PROCEEDINGS DURING THE PRECEDING FIVE YEARS


Check  whether  the  registrant  filed  all documents and reports required to be
filed  by  Section 12, 13 or 15(d) of the Exchange Act after the distribution of
securities  under  a  plan  confirmed  by  a  court.  Yes  [  ]  No  [  ]


                      APPLICABLE ONLY TO CORPORATE ISSUERS

State the number of shares outstanding of each of the issuer's classes of common
equity,  as of the latest practicable date.     2,636,887 shares of common stock
as  of  March  20,  2000
                           --------------------------

Transitional  Small  Business  Disclosure  Format  (Check  one)  Yes [ ]  No [X]


<PAGE>
                         PART I - FINANCIAL INFORMATION


<TABLE>
<CAPTION>
                        ACCESS HEALTH ALTERNATIVES, INC.
                           CONSOLIDATED BALANCE SHEET
                                   (UNAUDITED)



                              MARCH 31,   DECEMBER 31,
                                 2000         1999
                              ----------  ------------
<S>                           <C>         <C>
ASSETS
----------------------------

Current assets:
  Cash                        $    1,112         1,757
  Receivables:
    Trade, net                    57,986        58,923
    Other                          4,380         4,380
                              ----------  ------------

        Total receivables         62,366        63,303
  Inventories                    127,737       144,250
                              ----------  ------------

        Total current assets     191,215       209,310

Property and equipment, net       48,378        52,357
Other assets                       5,050         5,050
Deferred rescission costs        640,663       640,663
                              ----------  ------------

        Total assets          $  885,306       907,380
                              ==========  ============
</TABLE>


See accompanying notes to consolidated financial statements.


<PAGE>
<TABLE>
<CAPTION>
                        ACCESS HEALTH ALTERNATIVES, INC.
                      CONSOLIDATED BALANCE SHEET, CONTINUED
                                   (UNAUDITED)



                                                                   MARCH 31,    DECEMBER 31,
                                                                      2000          1999
                                                                  ------------  -------------
<S>                                                               <C>           <C>
           Liabilities and Stockholders' Deficit

Current liabilities:
  Notes and commercial paper                                      $ 1,555,201      1,491,348
  Current obligation under capital lease                                7,213          8,847
  Bank overdraft                                                        4,408          8,016
  Accounts payable                                                    430,333        404,935
  Accrued liabilities                                                 884,208        610,511
  Due to related parties:
    Stockholders                                                      198,086        185,137
    Limited liability companies including recision                  1,603,809      1,603,809
      of $763,750 to be offered to holders of economic
      interests at September 30, 1999
    Access Healthcare, Inc.                                            35,510         29,651
                                                                  ------------  -------------

        Total due to related parties                                1,837,405      1,818,597
                                                                  ------------  -------------

        Total current liabilities                                   4,718,768      4,342,254

Unearned income                                                       253,731        274,370
Obligation under capital lease, less current portion                   10,749         10,749
Minority interest in subsidiary                                       129,545        129,545
                                                                  ------------  -------------

        Total liabilities                                           5,112,793      4,756,918

Stockholders' deficit:
  Preferred stock, $.01  par value, 10,000,000 shares authorized
    none issued                                                             -              -
  Common stock, $.001 par value, 50,000,000 shares authorized,
    2,626,787 shares issued and outstanding                             2,627          2,627
  Capital in excess of par value                                    1,530,217      1,530,217
  Accumulated deficit                                              (5,760,331)    (5,382,382)
                                                                  ------------  -------------

        Total stockholders' deficit                                (4,227,487)    (3,849,538)
                                                                  ------------  -------------

        Total liabilities and stockholders' deficit               $   885,306        907,380
                                                                  ============  =============
</TABLE>


See accompanying notes to consolidated financial statements.


<PAGE>
<TABLE>
<CAPTION>
                        ACCESS HEALTH ALTERNATIVES, INC.
                      CONSOLIDATED STATEMENTS OF OPERATIONS
                                   (UNAUDITED)



                                             THREE MONTHS ENDED
                                                  MARCH 31,
                                             2000             1999
                                     --------------------  ----------
<S>                                  <C>                   <C>
Revenues:
  Equipment                          $                 -           -
  Products                                        56,412      89,048
  Other                                           19,202      23,009
                                     --------------------  ----------

      Total revenues                              75,614     112,057

Cost of sales:
  Equipment                                            -           -
  Products                                        16,513      25,639
  Other                                                -         372
                                     --------------------  ----------

      Total cost of sales                         16,513      26,011
                                     --------------------  ----------

      Gross profit                                59,101      86,046

Selling, general and administrative              414,068     433,768
                                     --------------------  ----------

      Operating loss                            (354,967)   (347,722)

Other expense:
  Interest expense                                22,932      38,482
  Other, net                                          50           -
                                     --------------------  ----------

      Total other expense                         22,982      38,482
                                     --------------------  ----------

      Net loss                       $          (377,949)   (386,204)
                                     ====================  ==========

Basic net loss per share             $             (0.14)  $   (0.34)
                                     ====================  ==========
</TABLE>


See accompanying notes to consolidated financial statements.


<PAGE>
<TABLE>
<CAPTION>
                        ACCESS HEALTH ALTERNATIVES, INC.
                      CONSOLIDATED STATEMENT OF CASH FLOWS
                                   (UNAUDITED)


                                                                 THREE MONTHS ENDED
                                                                      MARCH 31,
                                                                 2000             1999
                                                         --------------------  -----------
<S>                                                      <C>                   <C>
Cash flows from operating activities:
  Net loss                                               $          (377,949)    (386,204)
  Adjustment to reconcile net loss to net cash provided
    by (used in) operating activities:
      Depreciation and amortization                                    3,979        8,598
      Losses of limited liability companies                                -       28,354
      Unearned income recognized                                     (20,639)     (19,500)
      Issuance of common stock for services                                -       63,280
      Cash provided by (used in) changes in:
          Receivables                                                    937       (2,939)
          Inventories                                                 16,513        2,540
          Other assets                                                     -   (28,711.00)
          Deferred rescission costs                                        -            -
          Bank overdraft                                              (3,608)      17,586
          Accounts payable                                            25,398      162,284
          Accrued liabilities                                        273,697        7,774
                                                         --------------------  -----------

        Net cash used in operating activities                        (81,672)    (146,938)

Cash flows from investing activities:
  Purchases of property and equipment                                      -       (4,382)
                                                         --------------------  -----------

Cash flows from financing activities:
  Payments on notes and commercial paper                                (913)     (80,793)
  Proceeds from notes and commercial paper                            64,766            -
  Due to stockholders                                                 12,949      (54,878)
  Advances (to) from limited liability companies                           -     (168,168)
  Due to related party                                                 5,859       (3,600)
  Payments on capital lease obligations                               (1,634)
  Proceeds from issuance of stock                                          -      485,000
                                                         --------------------  -----------

        Net cash provided by financing activities                     81,027      177,561
                                                         --------------------  -----------

  Net (decrease) increase in cash                                       (645)      26,241

    Cash at beginning of period                                        1,757          419
                                                         --------------------  -----------

    Cash at end of period                                $             1,112       26,660
                                                         ====================  ===========

Supplemental disclosure:
  Cash paid during the period for interest               $             4,515       33,129
                                                         ====================  ===========
</TABLE>


See accompanying notes to consolidated financial statements.


<PAGE>
                        ACCESS HEALTH ALTERNATIVES, INC.
                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS



(1)     ORGANIZATION

On  September  2,  1998, Access HealthMax Holdings, Inc. ("Holdings"), f/k/a PLC
Ventures  Corp.  ("PLC")  acquired approximately 94.3% of the outstanding common
stock of Access HealthMax, Inc. ("HealthMax"), for 565,100 shares of authorized,
but previously unissued common stock.  Immediately preceding the exchange, there
were 437,500 shares outstanding of PLC.  The shares of PLC had been issued for a
total consideration of $1,000.  PLC had no sales or revenues since its formation
on  October 2, 1988 and had zero stockholders' equity at the time of acquisition
of  HealthMax.  For  accounting purposes, the acquisition has been treated as an
acquisition  of  PLC  by  HealthMax  and  as  a  recapitilization  ("Reverse
Acquisition")  of  HealthMax.  The  historical  financial  statements  prior  to
September  2,  1998  are  those  of  HealthMax.  Pro  forma  information  is not
presented,  since  the  combination is a recapitilization rather than a business
combination.  The  deficiency  in  the  net  assets  of PLC were not adjusted in
connection  with the Reverse Acquisition since it consisted of accounts payable.

On March 11, 1999, Holdings changed its name to Access Health Alternatives, Inc.
("Alternatives").  Unless  the  context  indicates  otherwise,  references
hereinafter  to  (the  "Company")  include  HealthMax  and/or  Alternatives.

On  March 3, 1999, the Board of Directors authorized a ten-for-one reverse stock
split  effective  March 15, 1999.  All references in the financial statements to
number  of  shares,  per share amounts and market prices of the Company's common
stock have been retroactively restated to reflect the decreased number of common
shares  outstanding.



(2)     BASIS  OF  PRESENTATION

In  the  opinion  of management, the accompanying unaudited interim consolidated
financial  statements  include  all  adjustments necessary to present fairly the
financial  position of the Company, the results of its operations and cash flows
for  the  interim periods reported.  These adjustments are of a normal recurring
nature.  However,  the  accompanying  unaudited  interim  consolidated financial
statements  have  been  prepared  in  accordance  with  the  instructions  and
requirements  of  Form  10-QSB and Regulation S-B and, therefore, do not include
all  information  and  footnotes  for a fair presentation of financial position,
results  of  operations  and  cash  flows  in conformity with generally accepted
accounting  principles.

The  balance  sheet  as  of  December  31,  1999,  was  derived from the audited
consolidated balance sheet.  These statements should be read in conjunction with
the  financial  statements  included in the Company's Form 10-KSB filed with the
Securities  and  Exchange Commission, which include audited financial statements
for  the year ended December 31, 1999. The results of operations for the interim
periods  presented  are  not  necessarily  indicative of the results that may be
expected  for  the  year.


<PAGE>
                        ACCESS HEALTH ALTERNATIVES, INC.
                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS



(3)     LITIGATION

In  October,  1999  HealthMax  was advised by the Department of Professional and
Financial  Regulation,  Bureau  of Banking, Securities Division for the State of
Maine that certain sales of LLC's economic interests to Maine residents were not
covered by an exemption from registration, and were effected with the assistance
of  a  person  not  licensed to sell securities in that state, and therefore are
subject  to  rescission  to  the Maine investors, but has not yet determined the
manner  or  method  of this offer.  Neither the LLC's, HealthMax nor the Company
has sufficient funds available to return the full amount of the Maine investors'
interests  ($763,750),  should  they all elect to rescind their investment.  The
Company  has  recorded a liability previously recorded with respect to the state
of  Maine  investors  of $640,663.  The Company has recorded deferred rescission
costs  for  $640,663.

In  December  1999,  the Company became aware of an inquiry by the Comptroller's
office  of  the  State of Florida into the manner by which certain LLC interests
were  sold  to  residents of Florida.  The State has requested certain documents
and  information  from  the  Company,  from LLC's and from HealthMax in what the
Company  believes  is  an  effort  to  determine if securities were sold without
registration  or  without  an  exemption  from  registration,  or by persons not
licensed  to  sell securities in the State.  The Company is cooperating with the
State's  inquiry,  and  is unable to speculate at this time as to the outcome of
such  inquiry.  All LLC interests sold in the State of Florida are approximately
$1,472,000.

The  Company  has  been  notified  of two separate law  suits by various lenders
demanding, among other things, the enforcement of a settlement agreement between
the  lender  and  the  Company.  The Company believes the suit will be satisfied
upon  payment  of  all  outstanding  amounts  owed,  which  totals approximately
$200,000  and  is reflected as a liability on the balance sheet at September 30,
1999.


(4)     CONTINGENCY

At  December  31,  1999, the Company has suffered recurring losses and has a net
capital deficiency of $3,849,538 and a working capital deficiency of $4,132,944,
which raises substantial doubt about its ability to continue as a going concern.
The  Company  is  contemplating  a public or private offering of securities as a
means  of  raising  funds  to  implement  its  business  plan.

<PAGE>
                        ACCESS HEALTH ALTERNATIVES, INC.
                      NOTES TO CONSOLIDATED FINANCIAL STATEMENTS



(5)     SUBSEQUENT  EVENTS

VITACARE
April  18,  2000  the  Company  signed  a  letter  of intent to acquire Vitacare
Solutions,  Inc.  (Vitacare);  a  management  service  organization representing
affiliated  Independent  Physicians  Associations.  The  Company  will  acquire
Vitacare  in  an  all-stock  transaction.  The  transaction  is  subject  to the
completion  of  definitive  agreements  and  additional  due  diligence,  and is
expected  to  close  on  or  before  June  30,  2000.

ACCESS  HEATHCARE
The  Company agreed to acquire Access HealthCare, Inc. (Healthcare) during 1999,
subject  to  certain  conditions.  Under  the  terms  of  the acquisition, to be
accounted for as a pooling of interests, the Company will exchange approximately
2,000,000  shares  of  common  stock for all of HealthCare's outstanding shares.
HealthCare  operates  a  chiropractic  group practice in Central Florida and has
affiliated  chiropractic  practices  throughout  Florida.

If  the  acquisition  is  consummated,  the  financial  position  and results of
operations of the Company and HealthCare will be combined in 2000 retroactive to
January  1,  2000.  In addition, all prior periods presented will be restated to
give  effect  to  the  pooling.

Presented  below are condensed combined pro forma financial statements as of and
for  the  three  month  period  ended  March  31,  2000  to  give  effect to the
transaction.  The  condensed  combined  financial  statements  reflect  the
elimination  of  intercompany  transactions.

     Condensed  balance  sheet  at  March  31,  2000:

<TABLE>
<CAPTION>
                                       COMPANY     HEALTHCARE   ELIMINATIONS     COMBINED
                                     ------------  -----------  -------------  ------------
<S>                                  <C>           <C>          <C>            <C>
Assets:
Current assets                       $   191,215      249,218              -       440,433
Property & equipment, net                 48,378       75,003              -       123,381
Other assets                               5,050       35,722        (35,510)        5,262
Deferred rescission costs                640,663            -              -       640,663
                                     $   885,306      359,943        (35,510)    1,209,739
                                     ------------  -----------  -------------  ------------

Liabilities:
Current liabilities                  $ 4,718,768      505,754        (35,510)    5,188,012
Unearned income                          253,731            -              -       253,731
Long-term obligations                     10,749      123,108              -       133,857
Minority interest                        129,545            -              -       129,545
                                       5,112,793      628,862        (35,510)    5,706,145
                                     ------------  -----------  -------------  ------------
Stockholders' deficit                 (4,227,487)    (268,919)             -    (4,496,406)
                                     $   885,306      359,943        (35,510)    1,209,739

Condensed statement of operations:
Revenues                             $    75,614      571,646        (22,541)      624,719
Operating costs and expenses
                                         430,581      529,379        (22,541)      937,419
Operating income (loss)                 (354,967)      42,267              -      (312,700)
                                     ------------  -----------  -------------  ------------
Other expenses                           (22,982)     (15,440)             -       (38,422)
Net income (loss)                    $  (377,949)      26,827              -      (351,122)

Basic net loss per share                                                       $      (.13)

</TABLE>


<PAGE>
ITEM  2.  MANAGEMENT'S  DISCUSSION  AND  ANALYSIS  OR  PLAN  OF  OPERATION.

     The  following  discussion  and analysis should be read in conjunction with
the  financial  statements  of  the Company and the accompanying notes appearing
previously  under  the  caption "Financial Statements." The following discussion
and  analysis  contains  forward-looking  statements,  which  involve  risks and
uncertainties.  The  Company's  actual results may differ significantly from the
results,  expectations  and plans discussed in these forward-looking statements.

Results  of  Operations  for  the  Period  Ended  March  31,  2000 compared with
Periods  Ended  March  31,  1999

Management  believes  that  a  comparison  of  the  financial performance of the
Company  in  the  three  months  ended  March  31,  2000 and in the three months
ended  March  31,  1999  clearly  shows  the impact of a lack of capital and the
attention  of Senior Management to the establishment of a public trading  market
for  the  Company's  securities.

     During  the  quarter  represented,  the Company continues to down size it's
operations  in  light of the cash shortfall.  Certain operations and development
activities were suspended.  The resulting impact to Total Revenues was a decline
of  32.5%  dropping to $75,614.  This Revenue figure is expected to drop further
in the second quarter but will soon reach a base representing core ongoing sales
of the products.  Marketing activities during the quarter revolved around direct
mail  and  promotions  of  specific  products.  There  were  no increases in the
provider  network  as  all  regional sales and support activities were suspended
other  then  in  the  Central  Florida  market.

     Selling,  general  and administrative expenses declined slightly, 4.5%, and
is  expected  to  further  decline  in  the  second  quarter

Liquidity  and  Capital  Resources

     Continued  cash  flow shortages that have  slowed  the Company's growth and
diverted  management  attention to away from development activities. The Company
has  experienced  a  dramatic  rise  in accounts payable and accrued liabilities
increased from $1,015,446 at the beginning of the quarter to $1,314,541 or 29.5%
when  combined.  The  Company  continues  to  rely  on loans from affiliated and
unaffiliated  parties  to  cover  some of its cash flow shortfall.  As evidence,
Notes  and  commercial  paper  increased  by  $63,853  to $1,555,201. Loans from
stockholders  and  Access  Healthcare,  an  announced  acquisition, increased to
$198,086  and  $35,510  respectively.

     Accounts  receivables  and  other  Current  and  long  term assets remained
relatively  unchanged other then a reduction in Inventory of $16,513 to $127,737
reflecting  sales during the period.  Total asset decline of $22,704 to $885,306
explained  by  Inventory and depreciation.  There were no purchases or disposals
of  assets  during  the  period  other  then  in  the normal course of business.

     The  cash  used in operations for the three months ended March 31, 2000 and
1999  was  $81,672  and  $146,938  respectively.  The major items comprising the
cash  used  in  operations  were  losses  of  $377,949  and  $386,204,
respectively.


     The  Company  continues  to  experience negative cash flow, and anticipates
this continuing through the end of the current fiscal year.  Management believes
that additional funding will be necessary in order for it to continue as a going
concern.  In  April, the  Company initiated an offering to sell shares of Series
B  Preferred Stock.  Successful completion of this offering is expected to bring
$2,100,000  to  the  company  before  selling  costs  although  there  can be no
assurances  that the Company will be successful  in  procuring  such  financing.
The  Preferred  Offering  carries  a conversion to common stock, which, if fully
converted  will  result in the issuance of 2,800,000 shares.  The is a coupon of
8%  payable  quarterly.



<PAGE>
                           PART  II  -  OTHER  INFORMATION

ITEM  1.  LEGAL  PROCEEDINGS.

     There  were  no  new legal proceedings initiated against the company in the
first  quarter  if  2000.  Certain small claims actions and a suit by Innovative
Health  Products  were  either  settled  or  dismissed.

ITEM  2.  CHANGES  IN  SECURITIES

     On  April  2000,  the  Company designated the rights and preferences of its
Series  B  Redeemable Convertible Preferred Stock, and authorized the sale of up
to  2,800,000  common  shares  as  part  of  the  offering.

     In  January,  2000,  the  Company  issued  100,000 shares to each of Donald
Metchick  and  Steven  Miracle  pursuant  to  their  respective  Employment
agreements,  pursuant  to  Section  4(2).

ITEM  3.  DEFAULTS  UPON  SENIOR  SECURITIES

n/a

ITEM  4.  SUBMISSION  OF  MATTERS  TO  A  VOTE  OF  SECURITY  HOLDERS

n/a

ITEM  5.  OTHER  INFORMATION.

     In  April  2000,  the  Company  received confirmation that its registration
statement  on  Form  10SB  under  the  Securities  Exchange  Act  of  1934  (the
"Exchange  Act")  had  "cleared"  comments.  Subsequently  the  companies common
stock  regained  listing  on  the  Over  the  Counter  Bulletin  Board Exchange.

     In  April  2000,  the  Company,  and Vitacare Solutions, Inc. ("Vitacare"),
agreed  to  merge  in an all stock transaction.  The merger is contingent of due
diligence  and  definitive documents and is expected to close no later then June
30,  2000.


ITEM  6.  EXHIBITS  AND  REPORTS  ON  FORM  8-K

n/a



<PAGE>
                                   SIGNATURES

In accordance with the requirements of the Exchange Act, the Company caused this
report  to  be  signed  on  its  behalf  by  the  undersigned,  thereunto  duly
authorized.


                                   ACCESS  HEALTH  ALTERNATIVES,  INC.
                                   -----------------------------------
                                              (registrant)



     Date:   5/19/00                      /s/  Daniel  J.  Pavlik
            --------                     ---------------------------------------
                                                       (signature)*
                                         Daniel  J.  Pavlik,  President  &  CEO


     Date:   5/19/00                      /s/  Donald  Metchick
            --------                     ---------------------------------------
                                                       (signature)*
                                         Donald  Metchick,  Vice  President


     Date:   5/19/00                      /s/  Steven  Miracle
            --------                     ---------------------------------------
                                                       (signature)*
                                         Steven Miracle, Chief Operating Officer


*Print  the  name  and  title  of  each  signing  officer  under this signature.


<PAGE>